Skip to content
LATEST
Health

NHS Launches Clinical Trial for Multi-Cancer Diagnostic Blood Tests

A new NHS clinical trial involving 20,000 patients will test the efficacy of multi-cancer blood screenings to improve early detection of hard-to-diagnose…

NHS Launches Clinical Trial for Multi-Cancer Diagnostic Blood Tests

Health Service has initiated a clinical trial across 200 general practitioner surgeries to evaluate the efficacy of multi-cancer diagnostic blood tests. The study targets patients aged 45 and older presenting with non-specific abdominal symptoms, such as persistent pain or bloating. The trial aims to determine if identifying protein or DNA markers can improve the early detection of hard-to-diagnose cancers, including pancreatic, liver, and ovarian malignancies.

Approximately 20,000 participants will be enrolled to assess the diagnostic accuracy of these tests in a primary care setting. The results will inform potential future integration into standard clinical pathways for patients with vague symptoms. This initiative follows previous trials of similar diagnostic technologies that have faced challenges in demonstrating significant reductions in late-stage cancer diagnoses.

Successful implementation of these tests could alter diagnostic protocols for the 71,000 individuals diagnosed annually with these specific cancer types in England. The trial seeks to provide clinicians with objective data to prioritize urgent investigations, potentially reducing the diagnostic delay associated with abdominal cancers.

More stories

Latest news